[NEWS] Pitching accuracy rates of over 99% for multiple cancer screens, Thrive launches with $110 million - Loganspace
For more than 25 years the founders of Thrive Earlier Detection have been researching ways to improve the accuracy of liquid biopsy tests. The fruits of that labor from Dr. Bert Vogelstein, Dr. Kenneth Kinzler and Dr. Nickolas Papadopoulos — all professors and researchers at Johns Hopkins University — is CancerSEEK, a liquid biopsy test…
Er. Kodi
